![]() |
UMIN-CTR History |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Unique ID issued by UMIN | UMIN000004458 |
Receipt No. | R000005337 |
Scientific Title | Phase III trial evaluating the role of continuous letrozole versus intermittent letrozole following 4 to 6 years of prior adjuvant endocrine therapy for postmenopausal women with hormone-receptor positive, node positive early stage breast cancer |
Date of disclosure of the study information | 2010/11/01 |
Last modified on | 2020/05/14 15:23:06 |
No. | Disposal | Last modified on | Item of update | |
1 | Insert | 2010/10/27 14:19:07 | ||
2 | Update | 2012/05/02 10:44:38 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2012/09/12 15:52:33 | Recruitment status |
|
4 | Update | 2013/10/29 13:21:38 | Email Institutions |
|
5 | Update | 2013/10/29 13:36:00 | Institutions |
|
6 | Update | 2014/10/30 13:55:36 | Address Address TEL Address Address TEL |
|
7 | Update | 2014/10/30 13:59:17 | Key inclusion criteria |
|
8 | Update | 2016/05/09 09:17:57 | Name of primary sponsor Organization |
|
9 | Update | 2018/08/17 10:29:22 | Acronym Acronym |
|
10 | Update | 2018/08/23 17:39:21 | Public title |
|
11 | Update | 2018/08/24 10:05:09 | UMIN ID1 |
|
12 | Update | 2020/05/14 15:23:06 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Organization Organization Address Address Tel |